Heidi Ledford The CRISPR–Cas9 complex (white and blue) can cut DNA (green), disabling genes that cause disease.Credit: Ella Maru Studio/Science Photo Library Preliminary results from a landmark clinical trial suggest that CRISPR–Cas9 gene-editing can be deployed directly into the body to treat disease. The study is the first to show that the technique can be...
Issued on: 04/07/2020 – 11:50 India’s topmost medical research body said that it is attempting to launch the world’s first Covid-19 vaccine on August 15. However, health experts have questioned the short timeline. ADVERTISING The order by Balram Bhargava, director general of the Indian Council of Medical Research (ICMR) on Friday directs 12 hospitals selected...
Scientists of Far Eastern Federal University (FEFU), together with German and Russian colleagues, have developed a lead compound to fight chemotherapy-resistant prostate cancer. The original design comes out as scientists combine biologically active molecules from the chemically modified pigment of sea urchins with glucose molecules to deliver the active drug substance inward the tumor cells....
by Chris Adam, Purdue University More than one-third of the people in the United States who have epilepsy are at risk for a deadly complication called “sudden unexpected death in epilepsy.” That means 1.2 million people are at risk for the complication each year—and it will kill about 4,000 of them. They typically have refractory...
IN BRIEF Using a new version of CRISPR, researchers were able to genetically engineer cows, making them resistant to bovine tuberculosis. This innovation could dramatically reduce the overuse of antibiotics in livestock, and have a great impact on developing countries. CRISPR COWS Bovine tuberculosis is a disease that affects cows, but can also be transmitted...
